Creative Touch Permanent Makeup and Aesthetics

Fatty acids are carboxylic acids with a hydrocarbon chain – the structural units of triglycerides, phospholipids, and sphingolipids throughout the body. Their biological behaviour is governed by three variables: chain length, degree of saturation, and double bond position. These are not minor chemical distinctions. They determine whether a fatty acid fuels colonocytes or builds a stratum corneum lamellar phase, whether it stabilises a cell membrane or generates reactive aldehydes under oxidative stress, whether it drives inflammation or resolves it. The popular shorthand of “good fats versus bad fats” does not survive contact with the actual biology – individual fatty acids within both saturated and unsaturated categories behave in ways that contradict the category-level reputation, and skin biology in particular depends on distinctions that dietary simplifications erase entirely.

More Than “Good Fats and Bad Fats”

Fatty acids have been the subject of dietary advice warnings for decades, with saturated fat in particular the target of nutritional guidance that became embedded in public health messaging from the mid-20th century onwards. Whether that guidance accurately reflects the underlying evidence is a question that continues to generate scientific debate – and one on which this knowledge base takes no position, since cardiovascular nutrition is outside our scope. What we can say is that the category-level saturation framing – broadly: saturated fat bad, unsaturated fat good – does not survive contact with skin biology, where individual fatty acids behave in ways that contradict the category-level reputation entirely. Stearic acid is an 18-carbon saturated fatty acid that converts readily to oleic acid in the liver, has a distinct membrane biological role from palmitic acid, and triggers a specific mitochondrial fusion pathway in immune cells that no unsaturated fatty acid replicates. Sapienic acid is a monounsaturated fatty acid produced exclusively in human sebaceous glands, structurally similar to oleic acid but with the double bond at a different position – producing an entirely different biological profile and an antimicrobial function oleic acid does not share. ^[6]

The biology of fatty acids rewards specificity. The rest of this entity establishes the classification framework that makes that specificity legible.

The Classification Framework

Fatty acids are classified by three variables that interact to determine biological function.

Chain length – the number of carbon atoms in the hydrocarbon chain – is the first and most fundamental variable, because it determines how the fatty acid is absorbed, transported, and metabolised:

The chain length distinction also determines absorption route: SCFAs and MCFAs are absorbed directly into portal circulation and reach the liver rapidly; LCFAs require emulsification by bile salts and travel via the lymphatic system as chylomicrons before entering systemic circulation. VLCFAs are synthesised endogenously by elongase enzymes (ELOVL1, ELOVL4) in the endoplasmic reticulum and are degraded by peroxisomal rather than mitochondrial β-oxidation – a distinct metabolic pathway that becomes clinically relevant in peroxisomal disorders. eufic

Degree of saturation – the number of carbon-carbon double bonds – determines chemical reactivity and physical properties:

• Saturated fatty acids (SFAs) carry no double bonds. They are chemically stable, solid at room temperature in their pure form, and include palmitic acid (C16:0) and stearic acid (C18:0) as the most abundant in human skin and diet.
• Monounsaturated fatty acids (MUFAs) carry one double bond. Oleic acid (C18:1 Δ9) is the most abundant fatty acid in human sebum and olive oil; sapienic acid (C16:1 Δ6), produced exclusively in human sebaceous glands, is a MUFA whose unusual delta-6 double bond position distinguishes it completely from conventional MUFAs.
• Polyunsaturated fatty acids (PUFAs) carry two or more double bonds. The omega-3 and omega-6 families are both PUFA families; both contain essential members that the body cannot synthesise.

Double bond position – which carbon the first double bond falls on, counted from the methyl end (omega end) – determines omega family membership and the signalling cascade a fatty acid feeds into. An omega-6 fatty acid has its first double bond at carbon 6 from the methyl end; an omega-3 at carbon 3. This positional difference, which appears chemically trivial, produces opposing downstream effects – omega-6 metabolic pathways generate predominantly pro-inflammatory eicosanoids; omega-3 pathways generate anti-inflammatory resolvins and protectins. The two families compete for the same desaturase enzymes (delta-6, delta-5), so their relative dietary proportion directly influences which cascade predominates. ^[1]

Essential and Non-Essential Fatty Acids

Linoleic acid (LA, C18:2 omega-6) is the essential omega-6 fatty acid. Its role in acylceramide synthesis is specific and non-substitutable: LA is esterified at the omega position of Ceramide EOS and EOP – the ceramide subtypes that generate the long periodicity phase essential for stratum corneum permeability barrier architecture. When LA is absent or severely inadequate, oleic acid substitutes at this position, the long periodicity phase is disrupted, and barrier function deteriorates with measurably increased TEWL. In this strict biochemical sense, linoleic acid is essential for barrier integrity. ^[2]

The clinically important qualification is that the threshold for adequacy is low, and genuine deficiency is exceedingly rare. The minimum dietary intake required to prevent the deficiency syndrome – established by Holman (1960) from the triene:tetraene ratio as a biochemical marker – has been estimated at approximately 1–2% of total calories. Clinical EFA deficiency occurs almost exclusively in specific medical contexts: prolonged total parenteral nutrition without lipid supplementation, severe malabsorption syndromes, or extreme fat-restricted diets maintained over extended periods. Current Western dietary patterns provide approximately 6–8% of calories as linoleic acid, well above that minimum threshold. Linoleic acid is present in virtually all foods containing fat, including meat, eggs, dairy, nuts, and vegetables; complete avoidance is practically impossible on any normal dietary pattern.

The practical consequence is that for the vast majority of clients, ensuring adequate linoleic acid for Ceramide EOS synthesis is not a meaningful dietary challenge – it is already met. The relevant questions for skin health are not whether dietary LA is sufficient (it almost certainly is), but whether the Ceramide EOS synthesis pathway is functioning correctly (an enzymatic rather than substrate question), and whether the oxidative behaviour of excess linoleic acid in sebum and membrane phospholipids has consequences worth managing – a question explored in the Oxidative Stability section below, and developed further in the Linoleic Acid entity.

Alpha-linolenic acid (ALA, C18:3 omega-3) is the essential omega-3 fatty acid. It converts – inefficiently – to EPA and DHA via the same delta-6/delta-5 desaturase pathway that converts LA to arachidonic acid. Direct dietary EPA and DHA are substantially more bioavailable for the anti-inflammatory and membrane-structural roles these longer-chain omega-3s perform. Both LA and ALA are incorporated into membrane phospholipids in skin tissue, influencing membrane fluidity, signalling competency, and the inflammatory potential of the cell. ^[5]

Fatty Acids in Skin Biology – Four Contexts

Fatty acids appear in four distinct functional contexts in skin biology, each governed by different members of the fatty acid family:

1. Ceramide synthesis substrates in the stratum corneum – the barrier lipid matrix that provides the skin’s primary defence against water loss and environmental penetration depends on ceramides, whose synthesis requires both sphingoid bases and fatty acid chains. The elongase enzymes ELOVL1 and ELOVL4 produce the VLCFA chains (C22–C26+) that characterise the dominant ceramide subtypes in the stratum corneum. This is the context in which palmitic acid (C16:0) is most critical – as the direct substrate for serine palmitoyltransferase (SPT), the rate-limiting enzyme that initiates de novo ceramide synthesis. ^[7]

2. Sebum composition – sebaceous glands produce a distinct lipid mixture – triglycerides, wax esters, squalene, and free fatty acids – whose fatty acid composition is unlike that of any other body compartment. Uniquely in humans, the predominant fatty acid is sapienic acid (C16:1 Δ6), comprising approximately 25% of total sebum fatty acids, produced by Δ6-desaturase acting specifically on palmitic acid. Sapienic acid is then elongated and further desaturated to produce sebaleic acid (C18:2 Δ5,8), the predominant PUFA in human sebum – an omega structure found nowhere else in human biology. These fatty acids perform antimicrobial roles at the skin surface that are developed in the Sebum entity.

3. Membrane phospholipids and cell signalling – every cell membrane in the body, including keratinocytes and fibroblasts, is a phospholipid bilayer whose fatty acid composition determines membrane fluidity, receptor clustering, and downstream signalling. Saturated fatty acids increase membrane rigidity; unsaturated fatty acids, particularly PUFAs, increase fluidity. Dietary fatty acid composition directly alters membrane phospholipid profiles – this is the route by which omega-3 supplementation modulates immune cell signalling and the mechanism by which excess omega-6 arachidonic acid in membrane phospholipids increases the substrate pool available for pro-inflammatory eicosanoid synthesis when phospholipase A2 is activated. ^[4]

4. Oxidative stability in topical formulations – the same double bond vulnerability that makes PUFAs valuable as cellular signalling molecules makes them chemically unstable in topical preparations. Each additional double bond introduces a bis-allylic hydrogen position from which free radical abstraction initiates a self-propagating lipid peroxidation chain reaction, generating reactive aldehydes including 4-hydroxynonenal (4-HNE). This is why high-PUFA oils (rosehip, evening primrose, hemp) in poorly stabilised formulations oxidise to generate irritants, and why oxidative stability is a formulation consideration that extends to carrier oils, tallow, and any emollient containing meaningful proportions of omega-6 PUFAs. The oxidative stability gradient – SFAs most stable, MUFAs intermediate, PUFAs increasingly vulnerable with each additional double bond – runs directly through the fatty acid family. imrpress

Oxidative Stability – Why Double Bonds Matter

The mechanism behind PUFA oxidative vulnerability is worth establishing cleanly at the parent level, since it underpins content across multiple child entities in this knowledge base.

Lipid peroxidation initiates when a free radical abstracts a hydrogen atom from a bis-allylic position – the carbon between two double bonds – in a PUFA chain. This requires significantly less activation energy than hydrogen abstraction from saturated or monounsaturated carbon positions. The resulting lipid radical reacts with molecular oxygen to form a lipid peroxyl radical, which in turn abstracts hydrogen from a neighbouring PUFA, propagating a chain reaction that continues until a radical-trapping antioxidant ( vitamin E, for example) terminates it. The terminal reactive aldehydes – principally 4-HNE from omega-6 PUFAs – are electrophilic species that form protein adducts, modify enzyme activity, and trigger inflammatory signalling at concentrations well below those required for acute cytotoxicity. ^[3]

This chemistry applies equally in sebum, cell membranes, and topical formulations – the physical context differs but the oxidation mechanism is identical. Saturated fatty acids (no double bonds) do not participate in this chain reaction. Oleic acid (one double bond, no bis-allylic position) is substantially more resistant than linoleic acid (two double bonds, one bis-allylic position), which is more resistant than ALA (three double bonds, two bis-allylic positions), and so on through the PUFA families. The practical implications for formulation and dietary pattern design are developed in the individual fatty acid entities.

The downstream consequences of 4-HNE accumulation in skin tissue, including fibroblast senescence and SASP-driven inflammation, are developed in the Cellular Senescence and Inflammageing entities

Sebum’s Unusual Fatty Acid Profile

Human sebum is the only biological compartment in the body that contains sapienic acid and sebaleic acid in meaningful concentrations. Both are products of a metabolic pathway specific to human sebaceous glands – palmitic acid converted to sapienic acid by a Δ6-desaturase that operates here but not in other tissues, then sapienic acid elongated and further desaturated by FADS1 to produce sebaleic acid. No other mammal produces sapienic acid as a major sebum fatty acid; it appears to be a human-specific evolutionary development.

This metabolic specificity matters for two reasons. First, it means that the fatty acid profile of human sebum cannot be accurately modelled from animal sebum data or predicted from dietary fatty acid intake – it is driven by tissue-specific enzymatic activity, not substrate availability. Second, sapienic acid has antimicrobial activity against Staphylococcus aureus and contributes to the skin surface microbiome environment in ways that overlap with, but are mechanistically distinct from, the antimicrobial effects of the acid mantle generated by free fatty acids. The Sebum entity carries the full detail of sebum composition and function; this section establishes the connection between fatty acid biochemistry and sebum biology at the parent level.